Your browser doesn't support javascript.
loading
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease.
Zerbib, F; Bruley des Varannes, S; Roman, S; Tutuian, R; Galmiche, J-P; Mion, F; Tack, J; Malfertheiner, P; Keywood, C.
Affiliation
  • Zerbib F; Gastroenterology Department, CHU Bordeaux, Saint André Hospital, and Université Victor Segalen Bordeaux 2, Bordeaux, France.
Aliment Pharmacol Ther ; 33(8): 911-21, 2011 Apr.
Article in En | MEDLINE | ID: mdl-21320138
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroesophageal Reflux / Receptors, Metabotropic Glutamate / Heartburn Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroesophageal Reflux / Receptors, Metabotropic Glutamate / Heartburn Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Francia Country of publication: Reino Unido